AIFM1 and hepatocellular carcinoma: It acts independently of caspases in certain cancer cells, such as HepG2 hepatocellular carcinoma cells, where it induces G2/M phase cell cycle arrest and promotes the nuclear translocation of apoptosis-inducing factor (AIF), suggesting a mitochondrial mechanism independent of caspases [28].